| Issue Date | Title | Author(s) |
| 2021-10 | Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update | Krishnan, S; Thirunavukarasu, A; Jha, NK; Gahtori, R; Roy, AS; Dholpuria, S; Kesari, KK; Singh, SK; Dua, K; Gupta, PK |
| 2021 | Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression. | Satija, S; Kaur, H; Tambuwala, MM; Sharma, P; Vyas, M; Khurana, N; Sharma, N; Bakshi, HA; Charbe, NB; Zacconi, FC; Aljabali, AA; Nammi, S; Dureja, H; Singh, TG; Gupta, G; Dhanjal, DS; Dua, K; Chellappan, DK; Mehta, M |
| 2021-01-01 | Chapter 35 Targeting siRNAs in cancer drug delivery | Obeid, MA; Aljabali, AAA; Alshaer, W; Charbe, NB; Chellappan, DK; Dua, K; Satija, S; Tambuwala, MM |
| 2021-01-01 | Understanding the provision of a clinical service in mental health and the role of the pharmacist: A qualitative analysis | Fernandes, SAF; Brito, GDC; Dosea, AS; de Lyra Junior, DP; Garcia-Cardenas, V; Fonteles, MMDF |
| 2021-01-01 | Chapter 6 Material and strategies used in oncology drug delivery | Verma, N; Thapa, K; Dua, K |
| 2021-01-01 | Chapter 4 Emerging need of advanced drug delivery systems in cancer | Prasher, P; Sharma, M; Dua, K |
| 2021-08-30 | Radiotherapy in covid-19: A review | Sharma, L; Sharma, A; Nandy, SK; Kumar, AP; Singh, S; Chellappan, DK; Gupta, G; Dua, K; Kumar, D |
| 2021-11 | Self-nanoemulsifying composition containing curcumin, quercetin, Ganoderma lucidum extract powder and probiotics for effective treatment of type 2 diabetes mellitus in streptozotocin induced rats | Khursheed, R; Kumar Singh, S; Kumar, B; Wadhwa, S; Gulati, M; Anupriya,; Awasthi, A; Vishwas, S; Kaur, J; Corrie, L; Arya, KR; Kumar, R; Kumar Jha, N; Kumar Gupta, P; Zacconi, F; Dua, K; Chitranshi, N; Mustafa, G; Kumar, A |
| 2021-12-16 | Overcoming hydrolytic degradation challenges in topical delivery: Non-aqueous nano-emulsions. | Kadukkattil Ramanunny, A; Singh, SK; Wadhwa, S; Gulati, M; Kapoor, B; Khursheed, R; Kuppusamy, G; Dua, K; Dureja, H; Chellappan, DK; Jha, NK; Gupta, PK; Vishwas, S |
| 2021-01-01 | Chapter 2 Current practice in cancer pharmacotherapy | Pont, LG; Dua, K; Cutler, RL; Benson, H; Hagi, M; Cardenas, VG; Smit, CCH; Ao, A; Williams, KA |
